Search
for
Sort by
Research 30 of 54
- Temperature-dependent phase transition microemulsions for enhanced transdermal delivery of finasteride and silodosin
- Simultaneous Quantification of Dutasteride and Silodosin Using a Stability-Indicating RP-HPLC Approach
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Floppy Iris Syndrome
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Adverse effects of common medications on male fertility
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- The pathophysiology of delayed ejaculation
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Common urologic diseases in older men and their treatment: how they impact fertility
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Effects of 5-alpha reductase inhibitors
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- A concise review- Development of an analytical method and validation of dutasteride
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Medikamentöse Therapie des benignen Prostatasyndroms
- Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)